about
Cyclin D3 mediates synthesis of a hyaluronan matrix that is adhesive for monocytes in mesangial cells stimulated to divide in hyperglycemic mediumQuantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancerEffect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus.Transcriptional and post-translational modulation of myo-inositol oxygenase by high glucose and related pathobiological stresses.The Responses of Hyperglycemic Dividing Mesangial Cells to Heparin Are Mediated by the Non-reducing Terminal Trisaccharide.Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signalingEffect of castration on renal glycosaminoglycans and their urinary excretion in male and female rats with chronic renal failure.Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?Fluorescent-tagged heparan sulfate precursor oligosaccharides to probe the enzymatic action of heparitinase I.Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division.Proteoglycomics: recent progress and future challenges.Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.Reduced sulfation of chondroitin sulfate but not heparan sulfate in kidneys of diabetic db/db mice.Hyaluronan induces the selective accumulation of matrix- and cell-associated proteoglycans by mesangial cells.This article has been published in error and has been removed. It will be published shortly in a correct version
P2860
Q28583458-C8F55B31-B93A-4B4B-ABE3-8B6B0D0D10EAQ33803148-9569F6BB-B1B6-4813-9672-AC967F36668FQ34283956-AD93F628-DC6F-48C1-9321-1B288FB5E36DQ35144977-CE9D2F6B-ED0D-44F5-8780-F2B10D01BC3DQ36323528-0E7CA103-F1FD-43B9-9D2A-D8CD5256DB48Q37129456-FEAC40F5-B75A-4EB0-B402-9F6CB3AB5195Q37383817-0A6020E4-31E5-4617-9BD4-8D042C494D02Q37392107-13235789-8A60-41B9-AACC-579CA58CB0DBQ37469129-8923A138-992F-46E2-91ED-95D3DAC3D573Q37691659-16791530-8CCB-46D8-B09A-081F00FD4F83Q37745062-5729D094-3590-4611-9D07-8523C33F894CQ38661556-6D3F836C-FA2E-46BF-B586-A95ECFC03EB9Q39404017-9C2C13D7-3AF9-4688-9600-A027C0DA70B4Q41308623-74709719-4A46-447C-BFCE-901D3896A117Q56706483-002259B0-C201-474C-9E67-84B862CF6C4A
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Heparan sulfate analysis from diabetic rat glomeruli.
@en
Heparan sulfate analysis from diabetic rat glomeruli.
@nl
type
label
Heparan sulfate analysis from diabetic rat glomeruli.
@en
Heparan sulfate analysis from diabetic rat glomeruli.
@nl
prefLabel
Heparan sulfate analysis from diabetic rat glomeruli.
@en
Heparan sulfate analysis from diabetic rat glomeruli.
@nl
P2093
P2860
P356
P1476
Heparan sulfate analysis from diabetic rat glomeruli.
@en
P2093
Aimin Wang
Mark E Lauer
Vincent C Hascall
P2860
P304
P356
10.1074/JBC.M608823200
P407
P577
2006-10-12T00:00:00Z